Jing, Yuting
Ma, Yuying
Zhang, Hongxing
Wu, Zhenhu
Li, Yongwen
Li, Haoxuan
Huang, Minling
Lin, Lin
Xu, Yinji https://orcid.org/0000-0002-9286-8207
Funding for this research was provided by:
the Technology Planning Project of Guangzhou (202002020042)
Zhou Zhongying Academic Experience Inheritance Studio in Guangdong
the double first-class and high-level university discipline collaborative innovation team project of Guangzhou University of Chinese Medicine (2021XK27)
Article History
Received: 18 April 2022
Accepted: 29 December 2022
First Online: 30 January 2023
Declarations
:
: The study was registered with the Chinese Clinical Trial Registry (ChiCTR- 2100043543). Ethical approval (BF2020-236–02) was obtained from the Guangdong Provincial Hospital of Chinese Medicine Human Research Ethics Committee. All participants signed an informed consent form and their personal information was stored in the hospital and only used in this study to protect confidentiality. There is no anticipated harm and compensation for trial participants.
: Not applicable.
: The funding bodies are nonprofit organizations and offer financial support for the study. The funding bodies played no part in the design of the study or collection, analysis, and interpretation of data and in writing the manuscript. The sponsor is the primary investigator. She conceived the study, led the proposal and protocol development, and holds indemnity insurance and legal liability.